SYNLOGIC, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SYNLOGIC, INC. (SYBX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $6.00K, a 79.31% decline year-over-year.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $10.00K, a 60.00% decline year-over-year.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $30.00K, a 91.38% decline year-over-year.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $33.00K, a 67.33% decline year-over-year.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $117.00K, a 96.31% decline from fiscal 2024.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $3.17M, a 12.94% increase from fiscal 2023.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $2.81M, a 22.89% decline from fiscal 2022.
- SYNLOGIC, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.64M, a 8.27% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-11 | $16.00K 10-Q · filed 2026-08-11 | $46.00K derived: sum of 3 quarters · filed 2026-08-11 | $79.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-14 | $40.00K derived: sum of 2 quarters · filed 2026-05-14 | $73.00K derived: sum of 3 quarters · filed 2026-05-14 | $102.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $63.00K derived: sum of 2 quarters · filed 2026-03-12 | $92.00K derived: sum of 3 quarters · filed 2026-08-11 | $117.00K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $33.00K 10-Q · filed 2025-11-13 | $62.00K derived: sum of 2 quarters · filed 2026-08-11 | $87.00K 10-Q · filed 2025-11-13 | $435.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $29.00K 10-Q · filed 2026-08-11 | $54.00K 10-Q · filed 2026-08-11 | $402.00K derived: sum of 3 quarters · filed 2026-08-11 | $503.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $25.00K 10-Q · filed 2026-05-14 | $373.00K derived: sum of 2 quarters · filed 2026-05-14 | $474.00K derived: sum of 3 quarters · filed 2026-05-14 | $972.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $449.00K derived: sum of 2 quarters · filed 2026-03-12 | $947.00K derived: sum of 3 quarters · filed 2026-03-12 | $3.17M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $101.00K 10-Q · filed 2025-11-13 | $599.00K derived: sum of 2 quarters · filed 2025-11-13 | $2.82M 10-Q · filed 2025-11-13 | $3.62M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $498.00K 10-Q · filed 2025-08-07 | $2.72M 10-Q · filed 2025-08-07 | $3.52M derived: sum of 3 quarters · filed 2025-08-07 | $4.16M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $2.22M 10-Q · filed 2025-05-08 | $3.02M derived: sum of 2 quarters · filed 2025-05-08 | $3.66M derived: sum of 3 quarters · filed 2025-05-08 | $4.31M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $803.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.44M derived: sum of 2 quarters · filed 2025-03-06 | $2.09M derived: sum of 3 quarters · filed 2025-03-06 | $2.81M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $640.00K 10-Q · filed 2024-11-12 | $1.28M derived: sum of 2 quarters · filed 2024-11-12 | $2.00M 10-Q · filed 2024-11-12 | $2.88M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $645.00K 10-Q · filed 2024-08-08 | $1.36M 10-Q · filed 2024-08-08 | $2.24M derived: sum of 3 quarters · filed 2024-08-08 | $3.13M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $718.00K 10-Q · filed 2024-05-14 | $1.60M derived: sum of 2 quarters · filed 2024-05-14 | $2.49M derived: sum of 3 quarters · filed 2024-05-14 | $3.47M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.77M derived: sum of 2 quarters · filed 2024-03-19 | $2.75M derived: sum of 3 quarters · filed 2024-03-19 | $3.64M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $894.00K 10-Q · filed 2023-11-09 | $1.87M derived: sum of 2 quarters · filed 2023-11-09 | $2.76M 10-Q · filed 2023-11-09 | $3.56M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $977.00K 10-Q · filed 2023-08-10 | $1.87M 10-Q · filed 2023-08-10 | $2.67M derived: sum of 3 quarters · filed 2023-08-10 | $3.48M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $890.00K 10-Q · filed 2023-05-11 | $1.69M derived: sum of 2 quarters · filed 2023-05-11 | $2.50M derived: sum of 3 quarters · filed 2023-05-11 | $3.37M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.61M derived: sum of 2 quarters · filed 2023-03-29 | $2.48M derived: sum of 3 quarters · filed 2023-03-29 | $3.36M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $808.00K 10-Q · filed 2022-11-10 | $1.68M derived: sum of 2 quarters · filed 2022-11-10 | $2.56M 10-Q · filed 2022-11-10 | $3.36M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $876.00K 10-Q · filed 2022-08-11 | $1.75M 10-Q · filed 2022-08-11 | $2.56M derived: sum of 3 quarters · filed 2022-08-11 | $3.49M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $877.00K 10-Q · filed 2022-05-12 | $1.68M derived: sum of 2 quarters · filed 2022-05-12 | $2.61M derived: sum of 3 quarters · filed 2022-05-12 | $3.69M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $802.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.74M derived: sum of 2 quarters · filed 2022-03-17 | $2.81M derived: sum of 3 quarters · filed 2022-03-17 | $3.91M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $935.00K 10-Q · filed 2021-11-10 | $2.01M derived: sum of 2 quarters · filed 2021-11-10 | $3.10M 10-Q · filed 2021-11-10 | $4.14M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $1.07M 10-Q · filed 2021-08-12 | $2.17M 10-Q · filed 2021-08-12 | $3.21M derived: sum of 3 quarters · filed 2021-08-12 | $4.28M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $1.09M 10-Q · filed 2021-05-13 | $2.13M derived: sum of 2 quarters · filed 2021-05-13 | $3.20M derived: sum of 3 quarters · filed 2021-05-13 | $4.28M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.11M derived: sum of 2 quarters · filed 2021-03-25 | $3.18M derived: sum of 3 quarters · filed 2021-03-25 | $4.13M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $1.07M 10-Q · filed 2020-11-05 | $2.14M derived: sum of 2 quarters · filed 2020-11-05 | $3.09M 10-Q · filed 2020-11-05 | $3.97M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $1.07M 10-Q · filed 2020-08-06 | $2.02M 10-Q · filed 2020-08-06 | $2.90M derived: sum of 3 quarters · filed 2020-08-06 | $3.93M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $954.00K 10-Q · filed 2020-05-08 | $1.83M derived: sum of 2 quarters · filed 2020-05-08 | $2.86M derived: sum of 3 quarters · filed 2020-05-08 | $4.35M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | $872.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.90M derived: sum of 2 quarters · filed 2020-03-12 | $3.40M derived: sum of 3 quarters · filed 2020-03-12 | $4.32M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $1.03M 10-Q · filed 2019-11-12 | $2.52M derived: sum of 2 quarters · filed 2019-11-12 | $3.44M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $1.49M 10-Q · filed 2019-08-08 | $2.41M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $919.00K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $2.65M 10-K · filed 2019-03-12 | ||||
| 2016-12-31 | $369.00K 10-K · filed 2018-03-20 | $1.59M 10-K · filed 2017-03-15 | |||
| 2015-12-31 | $985.00K 10-K · filed 2017-03-15 | ||||
| 2014-12-31 | $408.00K 10-K · filed 2017-03-15 | ||||
| 2013-12-31 | $163.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |